Evidence map›Paper›PMID 24214979›Full record

ArticleThe Journal of biological chemistry2014

Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.

Hyon Ju Park, Mara Guariento, Mateusz Maciejewski, Richard Hauhart, Wai-Hong Tham, Alan F Cowman, Christoph Q Schmidt, Haydyn D T Mertens, M Kathryn Liszewski, Dennis E Hourcade and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Complement receptor 1 is the human erythrocyte receptor forProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Review
  4. Structural biology of complement receptors.Frontiers in immunology · 2023
    Review
  5. The Cellular and Molecular Interaction Between Erythrocytes andFrontiers in cellular and infection microbiology · 2022
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Hyon Ju ParkFrom the Washington University School of Medicine, Division of Rheumatology, Department of Internal Medicine, St. Louis, Missouri 63110.
Mara Guariento
Mateusz Maciejewski
Richard Hauhart
Wai-Hong Tham
Alan F Cowman
Christoph Q Schmidt
Haydyn D T Mertens
M Kathryn Liszewski
Dennis E Hourcade
Paul N Barlow
John P Atkinson
Washington University in St. Louis · USUniversity of Edinburgh · GBAustralian Synchrotron · AUUniversity of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

Viral Discovery in Rheumatoid ArthritisP30AR048335 · NIAMS · WASHINGTON UNIVERSITY · PI WEIHL, CONRAD C · 2001 to 2015
$8.9M
TRAINING IN THE IMMUNOLOGY OF RHEUMATIC DISEASEST32AR007279 · NIAMS · WASHINGTON UNIVERSITY · PI Megan Anne Cooper, Deborah J Lenschow · 1986 to 2026
$6.0M
Complement Receptor One (CRI): Structure/FunctionR01AI041592 · NIAID · WASHINGTON UNIVERSITY · PI ATKINSON, JOHN · 1997 to 2013
$3.9M
COMPLEMENT CONVERTASE: ASSEMBLY, FUNCTION AND REGULATIONR01AI051436 · NIAID · WASHINGTON UNIVERSITY · PI HOURCADE, DENNIS EMIL · 2003 to 2016
$3.7M
NIAID NIH HHS R01 AI041592NIAID NIH HHS R01 AI051436NIAMS NIH HHS P30 AR048335NIAMS NIH HHS P30 AR48335NIAMS NIH HHS T32 AR007279NIAMS NIH HHS T32 AR07279Wellcome TrustWellcome Trust 081179Wellcome Trust 085025
6 · The paper itself

Abstract

To survive and replicate within the human host, malaria parasites must invade erythrocytes. Invasion can be mediated by the P. falciparum reticulocyte-binding homologue protein 4 (PfRh4) on the merozoite surface interacting with complement receptor type 1 (CR1, CD35) on the erythrocyte membrane. The PfRh4 attachment site lies within the three N-terminal complement control protein modules (CCPs 1-3) of CR1, which intriguingly also accommodate binding and regulatory sites for the key complement activation-specific proteolytic products, C3b and C4b. One of these regulatory activities is decay-accelerating activity. Although PfRh4 does not impact C3b/C4b binding, it does inhibit this convertase disassociating capability. Here, we have employed ELISA, co-immunoprecipitation, and surface plasmon resonance to demonstrate that CCP 1 contains all the critical residues for PfRh4 interaction. We fine mapped by homologous substitution mutagenesis the PfRh4-binding site on CCP 1 and visualized it with a solution structure of CCPs 1-3 derived by NMR and small angle x-ray scattering. We cross-validated these results by creating an artificial PfRh4-binding site through substitution of putative PfRh4-interacting residues from CCP 1 into their homologous positions within CCP 8; strikingly, this engineered binding site had an ∼30-fold higher affinity for PfRh4 than the native one in CCP 1. These experiments define a candidate site on CR1 by which P. falciparum merozoites gain access to human erythrocytes in a non-sialic acid-dependent pathway of merozoite invasion.

Indexed as

Binding SitesComplement C3bComplement C4bErythrocytesHEK293 CellsHumansMembrane ProteinsMerozoitesMutagenesisNuclear Magnetic Resonance, BiomolecularPlasmodium falciparumProtozoan ProteinsReceptors, Complement 3bScattering, Small AngleSurface Plasmon ResonanceX-Ray DiffractionComplement C3bComplement C4bCR1 protein, humanMembrane ProteinsProtozoan ProteinsReceptors, Complement 3bRH4 protein, Plasmodium falciparumCell Surface ReceptorComplement SystemConvertasesMalariaNMRPlasmodiumProtein StructureReticulocyte-binding Homologue ProteinsSurface Plasmon Resonance (SPR)

Identifiers

PMID24214979
PMCPMC3879568
OpenAlexW1989103663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.